SecBot SecBot
6-K ·Filed Jul 30, 2026

GRFS

Grifols SA
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001104659-26-088529
Actionable Insight • Neutral

Monitor for any strategic shifts tied to the new Audit Committee Chair's background, but this filing alone does not warrant a trading response. Focus on upcoming earnings and the potential IPO of Grifols' U.S. Biopharma business as key catalysts.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$8.20
T+0 close · Jul 30, 2026 · via day close
Latest settled
−7.80%
T+60 · $7.56
Vs SPY
−10.27%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 30 $8.20entry
  2. T+1 · 4mo ago −4.02%α −4.73% · $7.87
  3. T+5 · 3mo ago −4.51%α −8.13% · $7.83
  4. T+20 · 3mo ago −4.63%α −8.60% · $7.82
  5. T+60 · 25d ago −7.80%α −10.27% · $7.56
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Grifols announced the resignation of independent director Iñigo Sánchez-Asiaín Mardones (Audit Committee Chair, Strategy Committee member) and the appointment of Joanna Susan Le Couilliard as independent director and Audit Committee Chair, along with Montserrat Muñoz Abellana to the Strategy Committee. This is a routine board refreshment with no material financial impact.

Key Facts

  • Iñigo Sánchez-Asiaín Mardones resigned as independent director, Audit Committee Chair, and Strategy Committee member effective July 29, 2026, after nearly 12 years of service.
  • Joanna Susan Le Couilliard appointed as independent director and Audit Committee Chair via co-option; she is a Cambridge graduate and Chartered Accountant with 20+ years of healthcare management experience.
  • Montserrat Muñoz Abellana appointed to the Strategy Committee replacing Sánchez-Asiaín.
  • All appointments were unanimous following proposals from the Appointments and Remuneration Committee.

Financial Impact

No financial impact; routine governance change.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (GRFS), Batch item 10001104659-26-088529
Document: 0001104659-26-088529-index-headers.html0001104659-26-088529
Document: 0001104659-26-088529-index.html0001104659-26-088529
Document: 0001104659-26-088529.txt0001104659-26-088529
6-K Filing (GRFS), Batch item 50001104659-26-088529
Document: 0001104659-26-088529-index-headers.html0001104659-26-088529
Document: 0001104659-26-088529-index.html0001104659-26-088529
Document: 0001104659-26-088529.txt0001104659-26-088529

Track record

7 reports on GRFS

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 2, 202614d ago 6-K Neutral 2/10 Entry $8.51 to $8.69 Now $8.73 +2.59% ▲ +2.12% +2.04% vs SPY
  2. Nov 2, 202614d ago 6-K Bullish 6/10 Entry $8.51 to $8.69 Now $8.73 +2.59% ▲ +2.12% +2.04% vs SPY
  3. Aug 10, 202614w ago Press Release Neutral 4/10 Entry $8.05 to $7.77 Now $8.73 +8.45% ▼ −3.48% −3.43% vs SPY
  4. Jul 30, 202615w ago 6-K Neutral 2/10 Viewing Entry $8.20 to $7.83 Now $8.73 +6.46% ▼ −4.51% −8.13% vs SPY
  5. Jul 16, 202617w ago Press Release Neutral 4/10 Entry $7.33 to $7.54 Now $8.73 +19.10% ▲ +2.86% +4.54% vs SPY
  6. Jun 18, 202621w ago 6-K Neutral 3/10 Entry $7.28 to $7.39 Now $8.73 +19.92% ▲ +1.51% +3.58% vs SPY
  7. Mar 17, 202634w ago Press Release Bullish 7/10 Entry $8.02 to $7.60 Now $8.73 +8.85% ▼ −5.24% −2.58% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens Wed (11h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 30, 2026